Balyasny Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-25,000
Closed -$1.9M 2796
2022
Q1
$1.9M Buy
+25,000
New +$1.98M 0.01% 1403
2021
Q4
Sell
-10,000
Closed -$756K 2281
2021
Q3
$756K Buy
+10,000
New +$794K ﹤0.01% 1395
2021
Q2
Sell
-100,000
Closed -$7.88M 2008
2021
Q1
$7.88M Buy
+100,000
New +$7.84M 0.04% 555
2017
Q4
Sell
-100,000
Closed -$7.29M 2080
2017
Q3
$7.29M Hold
100,000
0.03% 597
2017
Q2
$7.41M Buy
+100,000
New +$7.42M 0.03% 635
2013
Q4
Sell
-100,000
Closed -$935K 507
2013
Q3
$935K Buy
+100,000
New +$5.92M 0.01% 530

Other funds holding CL

Balyasny Asset Management's CL Position: Q1 2026 in Review

Balyasny Asset Management reduced its Colgate-Palmolive (CL) stake by 99% in Q1 2026, selling an estimated $265M and leaving 18,707 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1889.

Balyasny Asset Management first reported a position in CL in Q3 2013 and has held it in 29 quarters since. The position peaked at $237M in Q4 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Balyasny Asset Management held 18,707 shares of Colgate-Palmolive worth $1.59M as of Q1 2026.
  • Balyasny Asset Management sold 2,976,512 Colgate-Palmolive shares in Q1 2026, an estimated $265M.
  • Colgate-Palmolive made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1889 holding.
  • Balyasny Asset Management first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 29 quarters since.
  • Balyasny Asset Management's Colgate-Palmolive position peaked at $237M in Q4 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.